Prot #STF 115469: A Multicenter, Randomized, Double-Blind, Phase 3 Study of the Safety, Efficacy, Systemic Exposure, and Pharmacodynamics of Calcipotriene Foam, 0.005%, Versus Vehicle Foam in Pediatric Subjects (Ages 2 to 11 Years) with Plaque Psoriasis

Project: Research project

Project Details

Effective start/end date3/13/133/13/20


  • PPD Development (Prot #STF 115469 // Prot #STF 115469)
  • GlaxoSmithKline LLC (Prot #STF 115469 // Prot #STF 115469)